Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 622 participants.

Also called NCT01762163

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 622 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01762163
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01762163. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
Intervention (Drug)
Qizhitongluo Capsule
Intervention (Drug)
Naoxintong Capsule
Intervention (Drug)
Aspirin Enteric-coated Tablets
Intervention (Behavioral)
the routine recovery training
Intervention (Drug)
placebo
Lead sponsor
China Academy of Chinese Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct01762163
Content hash
b3668b290fa9d6dd0ae7de4c10874fee8a853f71fdba1d70aabaf055603bc9a6